Cash Flow Citi Pharma Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,354.00
1,277.00
955.00
1,060.00
499.00
202.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1,378.00
279.00
-1,142.00
-1,221.00
263.00
-131.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-320.00
1,337.00
-328.00
-322.00
745.00
94.00
Cash Flow from Investing Activities
-112.00
-511.00
-780.00
-921.00
-276.00
-200.00
Cash Flow from Financing Activities
646.00
-958.00
863.00
-171.00
2,515.00
107.00
Net Cash Inflow / Outflow
213.00
-133.00
-246.00
-1,416.00
2,984.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in PKR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Citi Pharma Ltd.
Figures in Million
consolidated Cash Flow Results
Change(PKR)
Change(%)
Profit Before Tax
1354.50983
1525.194755
-171.00
-11.19%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1378.101304
-1017.199383
-361.00
-35.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-320.703217
898.619155
-1,218.00
-135.69%
Cash Flow from Investing Activities
-112.981993
-1721.80424
1,609.00
93.44%
Cash Flow from Financing Activities
646.823823
1459.322973
-813.00
-55.68%
Net Cash Inflow / Outflow
213.138613
636.137888
-423.00
-66.49%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'25
YoY Growth in year ended Jun 2025 is -123.98% vs 506.57% in Jun 2024
Jun'25
Jun'24
Change(%)
Cash Flow from Operating Activities
-320.70
1,337.60
-123.98%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
